Technical Description
The present invention relates to a non-invasive method for monitoring early renal damage by detecting N-acetyl β-D-glucosaminidase (NAG) in urine samples based on fluorescence assay.
Problems Addressed
- Renal Damage
- Elevated NAG Levels
- Non-Selective Method
- Non-Sensitivity
- Expensive
- Delayed Detection
Tech Features
- NAG Detection
- Non-Invasive Method
- Early Renal Damage Detection
- Rapid Detection
- High Specificity
- Improved Stability
- Detection at Low Concentration
- Cost-Effective
- Reliable Method
Target Audience
- Healthcare and Diagnostics Sector
- Pharmaceutical Industry
- Medical Device Manufacturing Sector
- Research & Development
Tech ID: P14-1352 TRL 3 Patent Status: Published Available For Exclusive and Non-exclusive License
